Skip to main content
Livermore
Livermore
ZHEN

Tenaya Therapeutics, Inc.

TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001858848

In the last 90 days, Tenaya Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 101 institutions reported holding it in 13F filings for Q2 2026, worth $39.7M in total; no superinvestor holds it.

Holders of 5% or more of TNYA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tenaya Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TNYA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Column Group III, LP13D/A23.10%49.3M shares−2.30 ppfrom 25.40%Feb 11, 20226 filingsFeb 26, 2026SEC
Integrated Core Strategies (US) LLC13G5.20%11.6M sharesNewAug 24, 20261 filingAug 24, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

27 Schedule 13D and 13G filings on Tenaya Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TNYA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 24, 20265:48 PM ETIntegrated Core Strategies (US) LLCand 3 others13G5.20%11.6M sharesNewAug 17, 2026SEC
Feb 26, 20264:29 PM ETColumn Group III, LPand 7 others13D/A23.10%49.3M shares−2.30 ppfrom 25.40%Feb 25, 2026SEC
Feb 12, 20266:52 PM ETColumn Group III, LPand 7 others13D/A25.40%54.3M shares+2.30 ppfrom 23.10%Feb 10, 2026SEC
Dec 17, 20254:16 PM ETColumn Group III, LPand 5 others13D/A23.10%49.3M shares−7.20 ppfrom 30.30%Dec 15, 2025SEC
Aug 14, 202511:59 AM ETWoodline Partners LP13G/A4.99%9.00M shares−1.81 ppfrom 6.80%Below 5%Jun 30, 2025SEC
Jul 31, 20254:36 PM ETEmpery Asset Management, LPand 2 others13G/A4.99%8.30M shares−4.97 ppfrom 9.96%Below 5%Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A1.70%2.73M shares−5.00 ppfrom 6.70%Below 5%Jun 30, 2025SEC
May 15, 20259:32 AM ETWoodline Partners LP13G6.80%5.92M sharesNewMar 31, 2025SEC
May 14, 20254:18 PM ETColumn Group III, LPand 5 others13D/A30.30%49.3M shares−1.70 ppfrom 32.00%May 7, 2025SEC
May 7, 20259:31 AM ETEmpery Asset Management, LPand 2 others13G9.96%8.73M sharesNewMar 31, 2025SEC
Mar 7, 20258:22 PM ETCasdin Capital, LLCand 3 others13D/A4.30%6.73M shares–Below 5%Mar 4, 2025SEC
Mar 7, 20257:50 PM ETColumn Group III, LPand 5 others13D/A32.00%49.3M shares–Mar 5, 2025SEC
Mar 6, 202510:52 AM ETJPMorgan Chase & Co13G/A2.80%2.28M shares−3.70 ppfrom 6.50%Below 5%Feb 28, 2025SEC
Feb 14, 20256:42 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 10, 202512:51 PM ETJPMorgan Chase & Co13G6.50%5.15M sharesNewDec 31, 2024SEC
Feb 5, 20251:23 PM ETBlackRock, Inc.13G/A6.70%5.30M shares–Dec 31, 2024SEC
Feb 14, 2022Walton Thomas Layton13GOld format–––SEC
Feb 14, 2022Walton Thomas Layton13GOld format–––SEC
Feb 14, 2022Ugwumba Chidozie13GOld format–New–SEC
Feb 14, 2022RTW Investments, LP13GOld format–New–SEC
Feb 14, 2022Price T Rowe Associates Inc13GOld format–New–SEC
Feb 11, 2022Column Group III, LP13GOld format–New–SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Aug 10, 2021FMR LLC13GOld format–New–SEC
Aug 9, 2021Ra Capital Management, L.P.13GOld format–New–SEC
Aug 9, 2021Walton Thomas Layton13GOld format–New–SEC
Aug 9, 2021Casdin Capital, LLC13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Tenaya Therapeutics, Inc. shares.

No Form 144 notices for Tenaya Therapeutics, Inc. are on file.